B4GALNT1 and cancer: Early mass spectrometry-based studies suggest that B4GALNT1 forms an anti-parallel, disulphide-mediated dimer19, while recent studies predicting the impact of HSP- and cancer-associated missense mutations used a monomeric AlphaFold2 (AF2) model of B4GALNT19,20.